ATE364398T1 - Perylenequinone zur anwendung mit immunotherapeutischen mitteln - Google Patents

Perylenequinone zur anwendung mit immunotherapeutischen mitteln

Info

Publication number
ATE364398T1
ATE364398T1 AT02701466T AT02701466T ATE364398T1 AT E364398 T1 ATE364398 T1 AT E364398T1 AT 02701466 T AT02701466 T AT 02701466T AT 02701466 T AT02701466 T AT 02701466T AT E364398 T1 ATE364398 T1 AT E364398T1
Authority
AT
Austria
Prior art keywords
compositions
present
perylenequinones
methods
immunotherapeutic agents
Prior art date
Application number
AT02701466T
Other languages
German (de)
English (en)
Inventor
Beatrice Leveugle
Original Assignee
Altachem Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altachem Pharma Ltd filed Critical Altachem Pharma Ltd
Application granted granted Critical
Publication of ATE364398T1 publication Critical patent/ATE364398T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02701466T 2001-01-30 2002-01-29 Perylenequinone zur anwendung mit immunotherapeutischen mitteln ATE364398T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26467701P 2001-01-30 2001-01-30

Publications (1)

Publication Number Publication Date
ATE364398T1 true ATE364398T1 (de) 2007-07-15

Family

ID=23007123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02701466T ATE364398T1 (de) 2001-01-30 2002-01-29 Perylenequinone zur anwendung mit immunotherapeutischen mitteln

Country Status (9)

Country Link
US (1) US20040110846A1 (enExample)
EP (1) EP1357944B1 (enExample)
JP (1) JP2004529091A (enExample)
CN (1) CN1665535A (enExample)
AT (1) ATE364398T1 (enExample)
AU (1) AU2002234809B2 (enExample)
CA (1) CA2436233C (enExample)
DE (1) DE60220642T2 (enExample)
WO (1) WO2002060482A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1349965A (zh) * 2000-10-25 2002-05-22 中国科学院感光化学研究所 带有脂肪环或芳香环的脂肪胺基取代去甲氧基竹红菌素及其合成方法和用途
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
JP2007513184A (ja) 2003-12-04 2007-05-24 バーテックス　ファーマシューティカルズ　インコーポレイテッド プロテインキナーゼのインヒビターとして有用なキノキサリン
JP5205264B2 (ja) 2005-08-10 2013-06-05 クウェスト・ファーマテック・インコーポレイテッド ペリレンキノン誘導体及びその使用
US8454991B2 (en) * 2006-07-24 2013-06-04 Quest Pharmatech Inc. Method and device for photodynamic therapy
CN102138640B (zh) * 2011-01-14 2012-12-05 江南大学 苝醌化合物在制备防治禽类病毒饲料中的应用
CN109456210B (zh) * 2017-09-06 2020-09-25 中国科学院理化技术研究所 一种竹红菌素迫位和2-位同时氨基取代的衍生物及其制备方法和应用
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
AU2020253403A1 (en) * 2019-03-29 2021-10-28 Children's Medical Center Corporation Targeted synergistic cancer immunotherapy
CN115282133A (zh) * 2021-12-06 2022-11-04 温州医科大学 竹红菌乙素在制备抗结肠癌药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1015033A4 (en) * 1997-01-10 2000-07-05 Altarex Inc SUBSTITUTED PERYLENEQUINONES FOR USE IN PHOTODYNAMIC THERAPY
GB9710049D0 (en) * 1997-05-19 1997-07-09 Nycomed Imaging As Method
AU757175B2 (en) * 1997-09-05 2003-02-06 Regents Of The University Of California, The Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation
EP1820514A3 (en) * 1998-06-15 2007-10-17 AltaRex Medical Corporation Therapeutic compositions that produce an immune response by altering the antigen
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
ATE290879T1 (de) * 1999-08-18 2005-04-15 Altarex Medical Corp Therapeutische antikörper gegen das muc-1 antigen und verfahren zu deren verwendung
ES2254408T4 (es) * 2000-04-25 2007-10-01 Immunex Corporation Procedimiento de tratamiento de tumores usando terapia fotodinamica.
US6627664B2 (en) * 2001-01-30 2003-09-30 Altachem Pharma Ltd. Perylenequinones for use as sonosensitizers
ATE554763T1 (de) * 2001-02-06 2012-05-15 Quadra Logic Tech Inc Photodynamische therapie der mit der altersbezogenen makuladegeneration verbundenen okkulten chorioidalen neovaskularisation

Also Published As

Publication number Publication date
CA2436233C (en) 2010-10-05
US20040110846A1 (en) 2004-06-10
JP2004529091A (ja) 2004-09-24
CN1665535A (zh) 2005-09-07
CA2436233A1 (en) 2002-08-08
WO2002060482A2 (en) 2002-08-08
EP1357944A2 (en) 2003-11-05
DE60220642T2 (de) 2008-02-21
DE60220642D1 (de) 2007-07-26
EP1357944B1 (en) 2007-06-13
AU2002234809B2 (en) 2005-04-07
WO2002060482A3 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
IL214325A (en) Antibody against cmet, a drug that includes and uses it
WO2005037190A3 (en) Multiplex vaccines
FR20C1016I1 (enExample)
ATE412433T1 (de) Methoden zur behandlung von tumoren und metastasen unter verwendung einer anti-angiogenen und immun-therapien
ATE378403T1 (de) Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern
DE69942774D1 (de) Verwendung von bioadhaesiven und adjuvantien für die mukosale anwendung von antigenen
TR200301846T2 (tr) Cripto bloke edici Antikorlar ve bu antikorların kullanımları.
DK1163008T3 (da) Anvendelse af trehalose til stabilisering af en flydende vaccine
WO2001092340A3 (en) Use of interleukin-4 antagonists and compositions thereof
DE69433406T2 (de) Antikörper gegen cd40
SG157952A1 (en) Small molecule antagonists of bcl-2 family proteins
DE69703121D1 (de) Verfahren und zusammensetzungen zur verhinderung von entzündungen und angiogenese enthaltend säugetieren cd97 alpha untereinheit
ATE364398T1 (de) Perylenequinone zur anwendung mit immunotherapeutischen mitteln
CR8231A (es) Anticuerpos rg1 y uso de los mismos
DK1362109T3 (da) Rekombinante oligomere protein-komplekser med foröget immunogent potentiale
DE69942742D1 (de) Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs
GB0318096D0 (en) Vaccine
WO1998013500A3 (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
DE60227080D1 (de) Lipidspiegel modulation mit steroiden und ppar-alpha agonisten
ATE511855T1 (de) Adjuvansformulierung zur scheimhaut-applikation
DK1255845T3 (da) Modificerede cytokiner til anvendelse i cancerterapi
DK1053017T3 (da) Vacciner omfattende interleukin-12 og herpes simplex virusantigen
MX2025005092A (es) Anticuerpo anti-trem2 y usos del mismo
TW200640947A (en) Novel polypeptide ligands for toll-like receptor 2 (TLR2)
DK0640131T3 (da) Gensplejsere antistoffer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties